Suggestions
Bruce Booth
Partner at Atlas Venture
Bruce Booth is a prominent early stage biotech investor with a primary focus on initiating and financing new companies dedicated to pioneering new therapeutic solutions. He holds a D.Phil. in Immunology from the University of Oxford and a B.S. in Biochemistry from Penn State University. Bruce Booth has an extensive history of serving in leadership roles across various organizations in the biotech industry. Previously, he has been a Board Director at Matchpoint Therapeutics, Sionna Therapeutics, Vigil Neuroscience, Arkuda Therapeutics, HotSpot Therapeutics, Kymera Therapeutics, AVROBIO, Nimbus Therapeutics, Quench Bio, Magenta Therapeutics, Unum Therapeutics, Lysosomal Therapeutics Inc, Quartet Medicine, Padlock Therapeutics, Numerate, Inc, Rodin Therapeutics, Bicycle Therapeutics, miRagen Therapeutics, Inc, and Zafgen, Incorporated. Additionally, Bruce Booth has served as a Partner at Atlas Venture.
